Design, synthesis, and optimization of Honokiol-Piperazine derivatives as lung-enriched agents against MRSA pneumonia infection
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.109694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Ruixue Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, No. 55 Daxuecheng S…. Hauptthemen laut MEDLINE: Lignans, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Drug Design. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Chongqing Academy of Science and Technology.
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA) causes severe bacterial pneumonia; current therapies (e.g., vancomycin) suffer from poor pulmonary bioavailability and dose-limiting safety concerns, demanding precision lung-enriched agents. However, small-molecule lung-enriched antibacterials are relatively rare. Honokiol (HNK), a natural phenolic compound with broad pharmacological activities but moderate antibacterial potency and limited tissue selectivity, was selected as the scaffold. We integrated a piperazine moiety into HNK and synthesized a series of HNK-piperazine derivatives. Among them, 13f showed potent activity primarily against Gram-positive bacteria, including MRSA (MIC: 2-4 μM; 16-32-fold more potent than HNK) together with preferential lung exposure. 13f exhibited rapid bactericidal activity and showed minimal MIC shift under sub-MIC selection over 31 serial passages (MICₙ/MIC₀ = 1-2), whereas ciprofloxacin displayed a 256-fold increase over the same period; it also attenuated staphyloxanthin production and reduced biofilm biomass. Mechanistic assays suggested time- and concentration-dependent membrane-associated effects, as reflected by permeability/depolarization readouts, nucleic acid/protein leakage, SEM imaging, and complementary MD analyses, with more pronounced effects at higher exposures. Pharmacokinetic and biodistribution analyses revealed a 13-fold longer half-life and a 147.92-fold higher lung AUC for 13f than for HNK. In a murine MRSA pneumonia model, 13f substantially reduced pulmonary bacterial burden and showed in vivo activity in the same overall range as vancomycin under the tested dosing regimen. No obvious histopathological alterations were observed under the tested short-term conditions. Overall, this work demonstrated a small-molecule approach to combine lung enrichment with potent anti-MRSA activity, supporting the further preclinical evaluation of 13f for MRSA pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, No. 55 Daxuecheng South Rd., Shapingba, Chongqing 401331, PR China.
- School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, No. 55 Daxuecheng South Rd., Shapingba, Chongqing 401331, PR China; Zhongshan Institute f…
- Chongqing Academy of Science and Technology, Chongqing 401123, China. Electronic address: phaibo2024@163.com.
- School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, No. 55 Daxuecheng South Rd., Shapingba, Chongqing 401331, PR China; Translational Innovat…
Förderung
- Chongqing Academy of Science and Technology
Zitieren
APA
Zhang, R., Zhong, Y., Gong, H., Deng, X., Peng, H., & He, Y. (2026). Design, synthesis, and optimization of Honokiol-Piperazine derivatives as lung-enriched agents against MRSA pneumonia infection. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109694
Vancouver
Zhang R, Zhong Y, Gong H, Deng X, Peng H, He Y. Design, synthesis, and optimization of Honokiol-Piperazine derivatives as lung-enriched agents against MRSA pneumonia infection. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109694
BibTeX
@article{Zhang2026,
author = {Zhang, Ruixue and Zhong, Yifan and Gong, Hongzhi and Deng, Xinyue and Peng, Haibo and He, Yun},
title = {Design, synthesis, and optimization of Honokiol-Piperazine derivatives as lung-enriched agents against MRSA pneumonia infection},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.109694}
}
EUVIMED